17Aug
UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By:
Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-82301/
Related
The debate continues in the United Kingdom as to how non-disclosure and confidentiality agreements s...
Read More >
The National Labor Relations Board announced a number of changes to its representation election rule...
Read More >
Last week, the EEOC announced that it does not intend to renew its request for authorization to coll...
Read More >
This newsletter is our take on the antitrust developments we think are most interesting to your busi...
Read More >
For some reason, my unincorporated village doesn’t have a mayor or village board of trustees, but w...
Read More >
Seyfarth Synopsis: The California Supreme Court has held that an individual may not seek unpaid wage...
Read More >